Chemistry: analytical and immunological testing – Cancer
Reexamination Certificate
1998-10-23
2004-03-30
Salimi, Ali R. (Department: 1642)
Chemistry: analytical and immunological testing
Cancer
C435S004000, C435S007100, C435S007200, C435S007210, C435S007230, C530S387100, C530S388100, C530S388200, C530S388800, C530S389100, C530S389700
Reexamination Certificate
active
06713305
ABSTRACT:
The present invention relates to a novel antigen which is closely associated with metastatic behaviour of tumour cells in vitro and in vivo, as well as to antibodies recognising said antigen and uses thereof in diagnosis and treatment of malignancies.
Metastasis is a multi-stage process by which tumour cells leave the site of a primary tumour, enter blood and lymph vessels, migrate to distant parts of the body and form novel foci of tumour growth. In keeping with the apparently complex nature of metastasis, experimental data suggest that no one factor is exclusively responsible for the determination of metastatic potential. Rather, a cascade of events, each of which incrementally increases the liability of a tumour to metastasis, leads to metastasis and tumour spread. Each of the events of the metastatic cascade is not believed to play a role of identical importance in each metastatic situation. A given metastatic cell is likely to possess some less developed metastatic properties, but still possess high metastatic potential because other properties are highly pronounced.
For this reason, a reliable marker for metastatic potential is difficult to determine. There are indications, however, that the cell surface is closely involved with many aspects of the metastatic cascade. The detachment of tumour cells, migration through tissues and final attachment to form a new focus of growth are events which all involve the behaviour of the cell surface.
It is known to attempt to raise antibodies directed to antigens preferentially expressed by tumour cells which show metastatic potential. For example, Vollmers and Birchmeier, (1983) PNAS 80, 3739-3733 & 6863-6867, demonstrated that certain antibodies raised to mouse melanoma cell line surface protein were able to inhibit cell adhesion and block metastasis. The antibodies appeared to target antigens of between 40 and 50 kDa.
By raising antisera to membrane associated proteins and assessing cross-reactivity with transformed cells, we have now been able to identify novel 150 kDa cell-surface proteins which correlate extremely closely with metastatic potential both in vitro and in vivo.
SUMMARY OF THE INVENTION
According to the present invention, we provide membrane-associated polypeptides having the sequence shown in SEQ ID NOS. 2 and 9, respectively. Also provided are immunogenic determinants derived from said polypeptides and antibodies raised thereto. The polypeptides, their derived antigenic determinants and the antibodies are useful for the diagnosis and treatment of metastatic potential in tumours.
REFERENCES:
patent: 0 239 400 (1987-03-01), None
patent: WO 90/07861 (1990-07-01), None
patent: WO9741221 (1997-11-01), None
Joswig G. et al., Journal of Cell Science, vol. 98, “Murine cDNAs coding for the centrosomal antigen centrosomin A,” pp. 37-43 (1991).
Nagase T. et al., Kazusa DNA Res., Univ. Acad. Press, Inc. Tokyo, vol. 2, “Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1,” pp. 167-174 (1995).
Nomura N., EMBL Sequence Database, Heidelberg, BRD, Acc. No. D50929, Aug. 1, 1996.
Fisher R., et al., EMBL Sequence Database, Heidelberg, BRD, Acc. No. U14172, Feb. 29. 1996.
Hillier L. et al., EMBL Sequence Database, Heidelberg, BRD, Acc. No. H08975, Jul. 2, 1995.
Hillier L. et al., EMBL Sequence Database, Heidelberg, BRD, Acc. No. N40943, Jan. 27, 1996.
Joswig G. et al., EMBL Sequence Database, Heidelberg BRD, Acc. No. X17373, Mar. 15, 1991.
Joswig G. et al., EMBL Sequence Database, Heidelberg, BRD, Acc. No. X84651, Feb. 13, 1995.
Kanner S.B. et al., Proc. Natl. Acad. Sci. USA, vol. 87, “Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases,” pp. 3328-3332, May 1990.
Scholler J.K. and Kanner S.B., EMBL Sequence Database, Heidelberg BRD, Acc. No. U58046, Feb. 2, 1997.
Bachmann F. et al., Cancer Res., vol. 57 (5), “Cloning of a Novel Protein Overexpressed in Human Mammary Carcinoma,” pp. 988-994 (1997).
Lupas A. et al., Science, vol. 252, “Predicting Coiled Coils from Protein Sequences,” pp. 1162-1164 (1991).
Mathias P. et al., Nucleic Acids Research, vol. 17 (15), “Eukaryotic expression vectors for the analysis of mutant proteins,” p. 6418 (1989).
Vollmers H.P. and Birchmeier W., Proc. Natl. Acad. Sci. USA, vol. 80, “Monoclonal antibodies inhibit the adhesion of mouse B 16 melanoma cells in vitro and block lung metastasis in vivo,” pp. 3729-3733 (1983).
Vollmers H.P. and Birchmeier W., Proc. Natl. Acad. Sci. USA, vol. 80, “Monoclonal antibodies that prevent adhesion of B 16 cells and reduce metastases in mice: Crossreaction with human tumor cells,” pp. 6863-6867 (1983).
Oct. 1995.*
Lin, M.C. et al. Structure-Function relationships in glucagon: Properties of highly purified Des-His-, Monoiodo-, and [Des-Asn28, thr29](homserine lactone27)-glucagon. Biochemistry, 14(8): 1559-1563, 1975.*
Burgess, W.H. et al. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J. Cell Biol., Nov. 1990.*
Ensinger, C. et al. Assignment of the p150 subunit of the eukaryotic initiation factor 3A gene (EIF3A) to human chromosome band 10q26 by in situ hybridization. Cyutogenet. Cell Genet. 83: 74-75, 1998.*
Scholler, J.K. et al. The human p167 gene encodes a unique structural protein that contains centrosomin A homology and associates with a multicomponent complex. DNA and Cell Biology 16(4): 515-531, Apr. 1997.
Bachmann Felix
Burger Max M.
Dohmann George R.
Lee Michael U.
Lopez Gabriel
Novartis AG
Salimi Ali R.
LandOfFree
Metastasis-associated antigen and antibodies thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metastasis-associated antigen and antibodies thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metastasis-associated antigen and antibodies thereto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3187677